Synthesis of Novel Methyl 3-(hetero)arylthieno[3,2-b]pyridine-2-carboxylates and Antitumor Activity Evaluation: Studies In Vitro and In Ovo Grafts of Chick Chorioallantoic Membrane (CAM) with a Triple Negative Breast Cancer Cell Line

doi:10.3390/molecules26061594

Paper

Synthesis of Novel Methyl 3-(hetero)arylthieno[3,2-b]pyridine-2-carboxylates and Antitumor Activity Evaluation: Studies In Vitro and In Ovo Grafts of Chick Chorioallantoic Membrane (CAM) with a Triple Negative Breast Cancer Cell Line

Published Mar 1, 2021 · Bruna R Silva, Rita Rebelo, Juliana M. Rodrigues

Molecules

Q1 SJR score

7

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

A series of novel functionalized methyl 3-(hetero)arylthieno[3,2-b]pyridine-2-carboxylates 2a–2h were synthesized by C-C Pd-catalyzed Suzuki-Miyaura cross-coupling of methyl 3-bromothieno[3,2-b]pyridine-2-carboxylate with (hetero)aryl pinacol boranes, trifluoro potassium boronate salts or boronic acids. Their antitumoral potential was evaluated in two triple negative breast cancer (TNBC) cell lines—MDA-MB-231 and MDA-MB-468, by sulforhodamine B assay. Their effects on the non-tumorigenic MCF-12A cells were also evaluated. The results demonstrated that three compounds caused growth inhibition in both TNBC cell lines, with little or no effect against the non-tumorigenic cells. The most promising compound was further studied concerning possible effects on cell viability (by trypan blue exclusion assay), cell proliferation (by bromodeoxyuridine assay) and cell cycle profile (by flow cytometry). The results demonstrated that the GI50 concentration of compound 2e (13 μM) caused a decreased in MDA-MB-231 cell number, which was correlated with a decreased in the % of proliferating cells. Moreover, this compound increased G0/G1 phase and decreased S phases, when compared to control cells (although was not statistic significant). Interestingly, compound 2e also reduced tumor size using an in ovo CAM (chick chorioallantoic membrane) model. This work highlights the potential antitumor effect of a novel methyl 3-arylthieno[3,2-b]pyridine-2-carboxylate derivative.

In Vitro Study

Study Snapshot

Novel methyl 3-(hetero)arylthieno[3,2-b]pyridine-2-carboxylate derivative shows potential antitumor activity in triple negative breast cancer cell lines and in ovo CAM models.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

Synthesis of Novel Methyl 3-(hetero)arylthieno[3,2-b]pyridine-2-carboxylates and Antitumor Activity Evaluation: Studies In Vitro and In Ovo Grafts of Chick Chorioallantoic Membrane (CAM) with a Triple Negative Breast Cancer Cell Line

Sign up to use Study Snapshot

References

Sorafenib Inhibits Proliferation, Migration and Invasion of Breast Cancer Cells

Sorafenib shows anti-cancer activity against breast cancer cells, potentially improving survival by inhibiting their invasive and metastatic properties.

Eucalyptus globulus Labill. decoction extract inhibits the growth of NCI-H460 cells by increasing the p53 levels and altering the cell cycle profile.

Eucalyptus globulus decoction extract inhibits the growth of NCI-H460 cancer cells by increasing p53 levels and altering the cell cycle profile, potentially offering potential anti-tumor activity.

Synthesis of novel 8-(het)aryl-6H-pyrano[4′,3′:4,5]thieno[3,2-b]pyridines by 6-endo-dig cyclization of Sonogashira products and halolactonizations with Cu salts/NXS. Preliminary antitumor evaluation

Novel 8-(het)aryl-6H-pyrano[4,3′:4,5]thieno[3,2-b]pyridines show promising antitumor activity, with a tricyclic lactone with a F atom in the meta position showing the most promising potential.

Synthesis of New Proteomimetic Quinazolinone Alkaloids and Evaluation of Their Neuroprotective and Antitumor Effects

New quinazolinone derivatives show neuroprotective and antitumor effects, with fumiquinazoline G (1) being the most potent, showing potential as lead compounds for treating neurodegenerative disorders and cancer.

Genetic Markers in Triple‐Negative Breast Cancer

Clinically relevant genetic markers for triple-negative breast cancer could serve as diagnostic, prognostic, or predictive tools, potentially improving personalized therapeutic strategies.

Citations

Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinoma

Darifenacin shows potential as a chemo sensitizer for pancreatic ductal adenocarcinoma treatment, targeting CHI3L1 and reversing drug resistance.

Chemosensitizing effect of pentoxifylline in sensitive and multidrug-resistant non-small cell lung cancer cells

Combining pentoxifylline with chemotherapy can improve non-small cell lung cancer treatment, even in cases of multidrug-resistant disease.

Experimental Tumor Induction and Evaluation of Its Treatment in the Chicken Embryo Chorioallantoic Membrane Model: A Systematic Review

The chorioallantoic membrane (CAM) model is a simple and effective technique for inducing tumors, testing treatments, and evaluating personalized medicine, but unification of methodology is needed.

Exploring the Potential of Montmorillonite as an Antiproliferative Nanoagent against MDA-MB-231 and MCF-7 Human Breast Cancer Cells

Montmorillonite nanosheets show potential as an antiproliferative nanoagent against MDA-MB-231 breast cancer cells, with higher vulnerability observed in MDA-MB-231 cells due to their higher proliferation rate.

Synthesis, Characterization and Apoptosis Capabilities of a Novel Naphthoquinone‐Derived Compound in Triple‐Negative Breast Cancer

A novel naphthoquinone compound shows potential as a new anti-malignant agent for treating triple-negative breast cancer by inducing cancer cell death and inhibiting cell migration.

Establishing and characterizing a novel doxorubicin-resistant acute myeloid leukaemia cell line

AML cell line HL60-CDR is a multidrug resistant model for studying drug resistance mechanisms in acute myeloid leukemia, providing an in vitro model for testing new compounds.

Pirfenidone Sensitizes NCI-H460 Non-Small Cell Lung Cancer Cells to Paclitaxel and to a Combination of Paclitaxel with Carboplatin

Pirfenidone sensitizes non-small cell lung cancer cells to paclitaxel treatment and a combination of paclitaxel and carboplatin, potentially improving treatment outcomes.